Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Corning wins U.S. funding for glass vials output for COVID-19 vaccines

Published 06/09/2020, 10:28 AM
Updated 06/09/2020, 10:30 AM
© Reuters. A screen displays the logo for Corning Inc. at the NYSE in New York
GLW
-
AZN
-
JNJ
-

(Reuters) - Glass maker Corning Inc (N:GLW) said on Tuesday it would receive $204 million from the U.S. government to boost manufacturing capacity of its vials that will be used to package coronavirus vaccines and treatments.

Companies developing coronavirus vaccines, such as AstraZeneca (L:AZN) and Johnson & Johnson (N:JNJ), have flagged potential supply shortages of glass vials, which could pose a challenge to scaling up the production of a vaccine.

Amid surging global demand, billions of vials will be needed for vaccines of the new coronavirus, with world leaders looking towards treatments as a way to re-open stalled economies.

Corning said it would provide priority access of its vials to companies that have tied up with Biomedical Advanced Research and Development Authority for developing treatments and vaccines.

© Reuters. A screen displays the logo for Corning Inc. at the NYSE in New York

This investment would help Corning scale up its manufacturing at three U.S. facilities. (https://reut.rs/3fd4yyd)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.